AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Salarius Pharmaceuticals, Inc. Director's Dealing 2017

Jan 20, 2017

Director's Dealing

Opens in your device viewer

Issuer: Flex Pharma, Inc. (FLKS)
CIK: 0001615219
Period of Report: 2017-01-18

Reporting Person: McCabe John P. (Chief Financial Officer)

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-01-18	Stock Option (right to buy)	$4.58	A	67000	Acquired	2027-01-18	Common Stock (67000.0)	Direct

F1: The stock option will vest in 48 successive equal monthly installments measured from January 18, 2017.